Product Wiki · Recalls · EU Safety Gate (RAPEX)

Table trois petits lapins — recall SR/01171/25

EU Safety Gate (RAPEX) · France · 2025-04-04 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/01171/25
Date of alert
2025-04-04
Country / jurisdiction
France
Risk level
Serious risk
Risk type
Choking
Brand
MOULIN ROTY
Product category
Furniture
Product type
Children's table
Barcode (EAN/GTIN)
3575676786024
Reported risk: Les pieds en caoutchouc de la table peuvent se détacher et être ingérés par un enfant utilisant la table, entraînant un risque d'étouffement. Le produit n'est pas conforme au règlement général sur la sécurité des produits.
Action taken by the authority
Type of economic operator taking notified measure
Importer
Category of measure
Withdrawal of the product from the market
Date of entry into force
10/03/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Table trois petits lapins

Risk Description (original English): The rubber feet of the table could be detached and ingested by a child using the table, leading to choking.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10093754

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.